BGI Genomics Co's revenue for the
three
months ended in Mar. 2024 was ¥821 Mil.
Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥4,216 Mil.
BGI Genomics Co's Revenue per Share for the
three
months ended in Mar. 2024 was ¥2.00.
Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥10.23.
Warning Sign:
BGI Genomics Co Ltd revenue per share has been in decline over the past 3 years.
During the past 12 months, the average Revenue per Share Growth Rate of BGI Genomics Co was -36.10% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -20.50% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 15.40% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 11.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 12 years, BGI Genomics Co's highest 3-Year average Revenue per Share Growth Rate was 56.10% per year. The lowest was -32.90% per year. And the median was 13.90% per year.
BGI Genomics Co Revenue Historical Data
The historical data trend for BGI Genomics Co's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of BGI Genomics Co's Revenue
For the Diagnostics & Research subindustry, BGI Genomics Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
BGI Genomics Co's Revenue Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, BGI Genomics Co's Revenue distribution charts can be found below:
* The bar in red indicates where BGI Genomics Co's Revenue falls into.
BGI Genomics Co Revenue Calculation
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥4,216 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BGI Genomics Co (SZSE:300676) Revenue Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
BGI Genomics Co Revenue Related Terms
Thank you for viewing the detailed overview of BGI Genomics Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
BGI Genomics Co (SZSE:300676) Business Description
BGI Genomics Co Ltd is a China-based company principally engaged in the provision of genomic class diagnosis and research services through the application of biotechnology. It offers its services in various research areas, such as agriculture and food science, cancer research, metagenomics, reproductive health, biomarker discovery, and drug discovery. The company mainly provides services for domestic and overseas academic institutions hospitals, medical institutions and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SZSE:300676 has been successfully added to your 